Diabetic nephropathy is a medical condition where the kidneys are damaged due to diabetes. High blood glucose levels damages the kidneys and allows the protein to enter the urine. Diabetic nephropathy can further lead to chronic kidney disease and kidney failure. Imaging, blood tests, urine tests are used to diagnose diabetic nephropathy.
MARKET DYNAMICS
Diabetic nephropathy market is anticipated to grow during the forecast period owing to increasing incidences of diabetes, shift to sedentary lifestyle, growing geriatric population and increased consumption of alcohol. Moreover, inorganic strategies by the market players like collaborations, mergers, and acquisitions by the market players are likely to create opportunities during the forecast period.
MARKET SCOPE
The "Global Diabetic nephropathy market analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of diabetic nephropathy market with detailed market segmentation by indication, treatment type, indication, diagnosis, end user and geography. The global diabetic nephropathy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading diabetic nephropathy market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global diabetic nephropathy market is segmented on the basis of indication, treatment type, indication, diagnosis, and end user. Based on indication, the market is segmented as type-1 diabetes, and type-2 diabetes. Based on treatment type, the market is segmented as diuretics, angiotensin receptor blockers, antioxidant inflammation modulator, calcium channel blockers, angiotensin-converting enzyme inhibitors (ace inhibitors), renin inhibitors, and others. Based on diagnosis the market is segmented into imaging tests, renal function testing, urine test, blood test, and renal biopsy. The end user segment is further divided into hospitals and clinics, ambulatory surgical centers, diagnostic centers, and research institutes.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global diabetic nephropathy market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The diabetic nephropathy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting diabetic nephropathy market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the diabetic nephropathy market in these regions.
MARKET PLAYERS
The report covers key developments in the diabetic nephropathy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from diabetic nephropathy market are anticipated to lucrative growth opportunities in the future with the rising demand for diabetic nephropathy market in the global market. Below mentioned is the list of few companies engaged in the diabetic nephropathy market.
The report also includes the profiles of key diabetic nephropathy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- ASTRAZENECA PLC
- BAYER AG
- NOVARTIS AG
- NOVO NORDISK AS
- MERCK AND CO., INC
- ALLERGAN, INC
- ABBOTT
- BOEHRINGER INGELHEIM GMBH
- ABBVIE INC
- PFIZER INC
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.